E. ÖZKAN Et Al. , "Impact of 18F FDG PET Ct for detecting primarp tumor focus in patients with histopathologically proven metastasis," International Journal of Nuclear Medicine Research , vol.3, pp.56-62, 2016
ÖZKAN, E. Et Al. 2016. Impact of 18F FDG PET Ct for detecting primarp tumor focus in patients with histopathologically proven metastasis. International Journal of Nuclear Medicine Research , vol.3 , 56-62.
ÖZKAN, E., SOYDAL, Ç., ARAZ, M., & KÜÇÜK, N. Ö., (2016). Impact of 18F FDG PET Ct for detecting primarp tumor focus in patients with histopathologically proven metastasis. International Journal of Nuclear Medicine Research , vol.3, 56-62.
ÖZKAN, ELGİN Et Al. "Impact of 18F FDG PET Ct for detecting primarp tumor focus in patients with histopathologically proven metastasis," International Journal of Nuclear Medicine Research , vol.3, 56-62, 2016
ÖZKAN, ELGİN Et Al. "Impact of 18F FDG PET Ct for detecting primarp tumor focus in patients with histopathologically proven metastasis." International Journal of Nuclear Medicine Research , vol.3, pp.56-62, 2016
ÖZKAN, E. Et Al. (2016) . "Impact of 18F FDG PET Ct for detecting primarp tumor focus in patients with histopathologically proven metastasis." International Journal of Nuclear Medicine Research , vol.3, pp.56-62.
@article{article, author={ELGİN ÖZKAN Et Al. }, title={Impact of 18F FDG PET Ct for detecting primarp tumor focus in patients with histopathologically proven metastasis}, journal={International Journal of Nuclear Medicine Research}, year=2016, pages={56-62} }